{"path":"Boxes/Temple College Nursing Program/LVN Program/Fall 24/Pharmacology/Documents/Module VIII/Pharmacology Chapt 30 PP.pdf","text":"Introduction to Clinical Pharmacology Chapter 30 Upper Respiratory System Drugs Copyright © 2022 Wolters Kluwer · All Rights Reserved Learning Objectives 1. Compare and contrast the classes of medications used for upper respiratory system problems. 2. Explain the uses, general drug actions, adverse reactions, contraindications, precautions, and interactions of intranasal steroids, antitussives, mucolytics, expectorants, antihistamines, and decongestants. 3. Distinguish important preadministration and ongoing assessment activities that should be performed on the client receiving intranasal steroids, antitussive, mucolytic, expectorant, antihistamine, or decongestant. 4. List nursing diagnoses particular to a client taking intranasal steroids, antitussive, mucolytic, expectorant, antihistamine, or decongestant. 5. Examine ways to promote an optimal response to therapy, manage common adverse reactions, and educate the client about the use of intranasal steroids, antitussive, mucolytic, expectorant, antihistamine, or decongestant. Copyright © 2022 Wolters Kluwer · All Rights Reserved Common Conditions of the Upper Respiratory System ▪ Rhinitis ▪ Nasal congestion ▪ Sneezing ▪ Cough ▪ Postnasal drip ▪ Sore throat ▪ Common colds Copyright © 2022 Wolters Kluwer · All Rights Reserved Histamine Production Copyright © 2022 Wolters Kluwer · All Rights Reserved Upper Respiratory System Drug Classes ▪ Intranasal Steroids ▪ Antihistamines ▪ Decongestants ▪ Antitussives ▪ Expectorants ▪ Mucolytics Copyright © 2022 Wolters Kluwer · All Rights Reserved Intranasal Steroids—Actions and Uses • Actions ▪ Also known as glucocorticoids ▪ Inhibit the response of cells such as mast cells, neutrophils, eosinophils, and macrophages and reduce mediators such as histamine which have an anti- inflammatory effect • Uses ▪ First-line treatment for symptoms of allergic rhinitis ▪ Nonallergic rhinitis ▪ Nasal polyps ▪ Chronic sinusitis Copyright © 2022 Wolters Kluwer · All Rights Reserved Inhaled Steroids—Adverse Reactions • Adverse Reactions: – Mild and unpleasant smell or taste – Dry nasal passages and epistaxis – Fungal infections (rarely) Copyright © 2022 Wolters Kluwer · All Rights Reserved Inhaled Steroids—Contraindications and Precautions • Contraindicated in clients with: • known hypersensitivity to steroids • pregnancy (pregnancy category C) • Use cautiously in clients: • taking systemic steroids • taking budesonide (increased blood levels of budesonide) • in children—slowed growth rate Copyright © 2022 Wolters Kluwer · All Rights Reserved Inhaled Steroids—Interactions Copyright © 2022 Wolters Kluwer · All Rights Reserved Antihistamines—Actions • Actions ▪ Antihistamines block most, but not all, of the effects of histamine ▪ First-generation antihistamines bind nonselectively to central and peripheral H1 receptors and may result in CNS stimulation or depression ▪ Other first-generation drugs may have additional effects: antipruritic (anti-itching) or antiemetic (antinausea) effects ▪ Second-generation antihistamines are selective for peripheral H1 receptors and, as a group, are less sedating Copyright © 2022 Wolters Kluwer · All Rights Reserved Antihistamines—Uses #1 • Uses ▪ Seasonal and perennial allergies ▪ Allergic and vasomotor rhinitis ▪ Allergic conjunctivitis ▪ Mild and uncomplicated angioneurotic edema and urticaria ▪ Allergic reactions to drugs, blood, or plasma ▪ Coughs caused by colds or allergy Copyright © 2022 Wolters Kluwer · All Rights Reserved Antihistamines—Uses #2 • Uses ▪ Adjunctive therapy in anaphylactic shock ▪ Treatment of parkin-like symptoms ▪ Relief of nausea and vomiting ▪ Relief of motion sickness ▪ Sedation ▪ Adjuncts to analgesics Copyright © 2022 Wolters Kluwer · All Rights Reserved Antihistamines—Adverse Reactions #1 • Central Nervous System Reactions: – Drowsiness or sedation – Disturbed coordination Copyright © 2022 Wolters Kluwer · All Rights Reserved Antihistamines—Adverse Reactions #2 • Respiratory System Reactions: – Dryness of mouth, nose, throat – Thickening of bronchial secretions Copyright © 2022 Wolters Kluwer · All Rights Reserved Antihistamines—Adverse Reactions #3 • Severe Adverse Reactions: – Hypersensitivity – Large doses can cause hyperthermia, tachycardia, confusion, sedation, delirium, hallucinations, blurry vision, dizziness, constipation, urinary retention, arrhythmias, seizures, and cardiac arrest Copyright © 2022 Wolters Kluwer · All Rights Reserved Antihistamines—Contraindications #1 • Contraindicated in clients with: • pregnancy (Pregnancy category B and C) • First-generation antihistamines: clients with known hypersensitivity to the drugs, newborns, premature infants, nursing mothers, individuals undergoing monoamine oxidase therapy, and in clients with angle- closure glaucoma, peptic ulcer, symptomatic prostatic hypertrophy, and bladder neck obstruction Copyright © 2022 Wolters Kluwer · All Rights Reserved Antihistamines—Contraindications #2 • Contraindicated in clients with: • Second-generation antihistamines: clients with known hypersensitivity • Cetirizine is contraindicated in clients who are hypersensitive to hydroxyzine Copyright © 2022 Wolters Kluwer · All Rights Reserved Antihistamines—Precautions • Use cautiously in clients with: ▪ bronchial asthma ▪ cardiovascular disease ▪ narrow-angle glaucoma ▪ hypertension ▪ impaired kidney function ▪ urinary retention ▪ pyloroduodenal obstruction ▪ hyperthyroidism Copyright © 2022 Wolters Kluwer · All Rights Reserved Antihistamines—Interactions #1 Interacting Drug Common Use Effect of Interaction Rifampin Antitubercular agent May reduce the absorption of the antihistamine (e.g., fexofenadine) MAOIs Antidepressant agent Increased anticholinergic and sedative effects of the antihistamine CNS depressants (e.g., opioid analgesics or alcohol) Pain relief Possible additive CNS depressant effect Copyright © 2022 Wolters Kluwer · All Rights Reserved Antihistamines—Interactions #2 Interacting Drug Common Use Effect of Interaction Beta blockers Management of cardiovascular disease Risk of increased cardiovascular effects (e.g., with diphenhydramine) Aluminum- or magnesium-based antacids Relief of GI problems or upset Decreased concentrations of drug in blood (e.g., fexofenadine) Copyright © 2022 Wolters Kluwer · All Rights Reserved Decongestants—Actions • Actions ▪ sympathomimetic drugs, which produce localized vasoconstriction of the small blood vessels of the nasal membranes ▪ vasoconstriction reduces swelling Copyright © 2022 Wolters Kluwer · All Rights Reserved Decongestants—Uses • Uses ▪ Used to treat congestion associated with: ➢Common cold ➢Hay fever ➢Sinusitis ➢Allergic rhinitis ➢Congestion associated with rhinitis Copyright © 2022 Wolters Kluwer · All Rights Reserved Decongestants—Adverse Reactions #1 • Topical Reactions: – Nasal burning – Nasal stinging – Nasal dryness Copyright © 2022 Wolters Kluwer · All Rights Reserved Decongestants—Adverse Reactions #2 • Oral Administration Reactions: – Tachycardia and other cardiac arrhythmias – Blurred vision – Nausea and vomiting Copyright © 2022 Wolters Kluwer · All Rights Reserved Decongestants—Contraindications and Precautions • Contraindicated in clients with: • known hypersensitivity to the drug or clients taking MAOIs • Use cautiously in clients with: • thyroid disease • diabetes mellitus • hypertension, cardiovascular disease, coronary artery disease, or peripheral vascular disease • prostatic hypertrophy • glaucoma Copyright © 2022 Wolters Kluwer · All Rights Reserved Decongestants—Interactions Interacting Drug Common Use Effect of Interaction MAOIs Antidepressant agent Severe headache, hypertension, and possibly hypertensive crisis Beta adrenergic blocking drugs Management of cardiovascular disease Initial hypertension episode followed by bradycardia Copyright © 2022 Wolters Kluwer · All Rights Reserved Antitussives, Expectorants, and Mucolytics— Actions ▪ Antitussives depress the cough center located in the medulla and are called centrally acting drugs (e.g., codeine); another mechanism is to act peripherally by anesthetizing stretch receptors in the respiratory passages (e.g., benzonatate) ▪ Expectorants increase the production of respiratory secretions, which in turn appears to decrease the viscosity of the mucus. (e.g., guaifenesin) ▪ Mucolytics reduce the viscosity of secretions by direct action on the mucus (e.g., acetylcysteine) Copyright © 2022 Wolters Kluwer · All Rights Reserved Antitussives, Expectorants, and Mucolytics— Uses ▪ Antitussives treat nonproductive cough ▪ Expectorants help bring up respiratory secretions ▪ Mucolytic acetylcysteine treats the following: ➢Acute bronchopulmonary disease ➢Tracheostomy care ➢Pulmonary compliance with cystic fibrosis ➢Pulmonary complications associated with surgery/anesthesia ➢Posttraumatic chest conditions ➢Atelectasis due to mucous obstruction ➢Acetaminophen overdosage Copyright © 2022 Wolters Kluwer · All Rights Reserved Antitussives, Expectorants, and Mucolytics— Adverse Reactions • Adverse Reactions when combined with an antihistamine: – Lightheadedness – Dizziness – Drowsiness – Sedation Copyright © 2022 Wolters Kluwer · All Rights Reserved Antitussives, Expectorants, and Mucolytics— Contraindications • Contraindicated in: • clients with known hypersensitivity to the drugs • premature infants or during labor when delivery of a premature infant is anticipated • clients with asthma (mucolytics) • pregnancy (pregnancy category D) (iodide) Copyright © 2022 Wolters Kluwer · All Rights Reserved Antitussives, Expectorants, and Mucolytics— Precautions #1 • Antitussives—use with caution in: • Clients with a persistent cough or a cough with excessive secretions, a high fever, persistent headache, and nausea and vomiting • Antitussives containing codeine are used with caution in clients during pregnancy (pregnancy category D), acute asthmatic attack, preexisting respiratory disorders, acute abdominal conditions, head injury, increased intracranial pressure, convulsive disorders, hepatic or renal impairment, and prostatic hypertrophy Copyright © 2022 Wolters Kluwer · All Rights Reserved Antitussives, Expectorants, and Mucolytics— Precautions #2 • Expectorants—use with caution in clients with: • Pregnancy (pregnancy category C) and labor (pregnancy category D) • persistent cough • severe respiratory insufficiency • asthma • elderly or debilitation Copyright © 2022 Wolters Kluwer · All Rights Reserved Antitussives, Expectorants and Mucolytics— Interactions #1 Copyright © 2022 Wolters Kluwer · All Rights Reserved Antitussives, Expectorants and Mucolytics— Interactions #2 Copyright © 2022 Wolters Kluwer · All Rights Reserved Pharmacology in Practice Exercise #1 ❖ Given below, in random order are the steps of the inflammatory response to injury. Arrange the steps of the inflammatory response in the order they are likely to occur in most situations. a) Dilation of the arterioles b) Increased capillary permeability c) Release of histamine d) Escape fluid from blood vessels e) Localized redness f) Localize swelling Copyright © 2022 Wolters Kluwer · All Rights Reserved Nursing Process—Client Receiving an Upper Respiratory System Drug #1 ❖ Preadministration Assessment • Objective Data • Vital signs • Weight (for pediatric clients) • Auscultate breath sounds Copyright © 2022 Wolters Kluwer · All Rights Reserved Nursing Process—Client Receiving an Upper Respiratory System Drug #2 ❖ Preadministration Assessment (continued) • Subjective Data • Type and duration of symptoms • Description of activity disruption by symptoms • Health history (especially regarding seasonal allergies or allergens in household) • Remedies attempted before seeking care Copyright © 2022 Wolters Kluwer · All Rights Reserved Pharmacology in Practice Exercise #2 ❖ What information should be obtained from the client by the nurse and documented prior to the recommendation of an antitussive? Select all that apply. a) Type of cough b) Presence of sputum c) Home remedies used to treat the cough d) Vital signs of the last PHCP visit Copyright © 2022 Wolters Kluwer · All Rights Reserved Nursing Process—Client Receiving an Upper Respiratory System Drug #3 ❖ Ongoing Assessment • Ask client about diminishing or worsening symptoms • If client returns to ambulatory setting or is in an inpatient setting, assess the client’s lung sounds and monitor vital signs Copyright © 2022 Wolters Kluwer · All Rights Reserved Nursing Process—Client Receiving an Upper Respiratory System Drug #4 ❖ Nursing Diagnosis • Injury Risk related to drowsiness, dizziness, or sedation • Ineffective Airway Clearance related to pooling of or thick secretions • Impaired Oral Mucous Membranes related to dry mouth, nose, and throat Copyright © 2022 Wolters Kluwer · All Rights Reserved Nursing Process—Client Receiving an Upper Respiratory System Drug #5 ❖ Planning • Expected client outcomes depend on the reason for administration of the drug but include: ▪ Optimal response to therapy ▪ Management of adverse drug reactions ▪ Confidence in an understanding of the prescribed medication regimen Copyright © 2022 Wolters Kluwer · All Rights Reserved Nursing Process—Client Receiving an Upper Respiratory System Drug #6 ❖ Implementation • Promoting Optimal Response to Therapy • Clients should be advised that if a cough lasts for more than 10 days or is accompanied by a fever, chest pain, severe headache, or skin rash that the client should consult the primary health care provider • Take height and weight annually of children taking long term inhaled steroids and compare to previous growth chart documentation • Reinforce teaching points specific to each medication Copyright © 2022 Wolters Kluwer · All Rights Reserved Nursing Process—Client Receiving an Upper Respiratory System Drug #7 ❖ Implementation • Monitoring and Managing Client Needs • Injury Risk • Assist the client with ambulation • Clear path to bathroom of hazards • Place the call light within easy reach and instruct to call before attempting to get out of bed and ambulating • In outpatient settings advise client not to engage in activities that require a clear mind or operation of equipment Copyright © 2022 Wolters Kluwer · All Rights Reserved Nursing Process—Client Receiving an Upper Respiratory System Drug #8 ❖ Implementation • Monitoring and Managing Client Needs • Ineffective Airway Clearance • In an inpatient setting have suction equipment readily available • In clients with thick sputum encourage fluids (up to 2000 mL per day if not contraindicated) • Instruct client to deep breathe and cough • Document color, amount, and consistency of sputum Copyright © 2022 Wolters Kluwer · All Rights Reserved Nursing Process—Client Receiving an Upper Respiratory System Drug #9 ❖ Implementation • Monitoring and Managing Client Needs • Ineffective Airway Clearance (continued) • Teach the client to take INS exactly as prescribed to avoid rebound nasal congestion • Suggest that the client use nasal saline irrigation using a “neti pot” Copyright © 2022 Wolters Kluwer · All Rights Reserved Nursing Process—Client Receiving an Upper Respiratory System Drug #10 ❖ Implementation • Monitoring and Managing Client Needs • Impaired Oral Mucous Membranes • Offer the client sips of water or ice chips to relieve symptoms of dry mouth, nose, and throat with the administration of antihistamines Copyright © 2022 Wolters Kluwer · All Rights Reserved Nursing Process—Client Receiving an Upper Respiratory System Drug #11 ❖ Implementation—Educating the Client and Family • Review the dosage regimen and possible adverse drug reactions with the client • Advise the client to read OTC drug labels carefully, follow the dosage recommendations and consult a PHCP if the cough persists for more than 10 days, the color of sputum changes, or the client develops fever or chest pain • For clients receiving acetylcysteine, the respiratory therapist typically gives the client and family instruction on how to maintain the equipment and administer the drug; the nursing role is to evaluate the client or family’s level of understanding of the drug regimen and has the opportunity to get all questions and answers addressed Copyright © 2022 Wolters Kluwer · All Rights Reserved Pharmacology in Practice Exercise #3 ❖ A nurse in a rehab facility is caring for a client with a tracheostomy who has a severe cough. The PHCP has prescribed acetylcysteine for the client. What is typically the nurse’s role when the drug is to be inserted into the tracheostomy? a) Ensure that the client is not receiving any other drug therapy b) Ensure that suction equipment is at the client’s bedside c) Ensure that the client gets continuous oxygen supply d) Ensure that the client keeps drinking warm water Copyright © 2022 Wolters Kluwer · All Rights Reserved Nursing Process—Client Receiving an Upper Respiratory System Drug #12 ❖ Implementation—Educating the Client and Family ❖ Teach the Client and Family: • Take the medication exactly as directed; do not exceed recommended dose • Avoid respiratory/allergy irritants • Drink fluids (1500 mL to 2000 mL per day) • Do not break open or chew capsules • Do not drink for 30 minutes after using a lozenge Copyright © 2022 Wolters Kluwer · All Rights Reserved Nursing Process—Client Receiving an Upper Respiratory System Drug #13 ❖ Implementation—Educating the Client and Family ❖ Teach the Client and Family (continued): • To treat dry mouth, take frequent sips of water or suck on sugarless hard candy or chew sugarless gum • Initial use may result in drowsiness; caution when driving or performing hazardous activities; effect will subside over time • To avoid alcohol or drugs Copyright © 2022 Wolters Kluwer · All Rights Reserved Nursing Process—Client Receiving an Upper Respiratory System Drug #14 ❖ Implementation—Educating the Client and Family ❖ Teach the Client and Family: (continued) • Teach methods to prevent and/or treat rebound congestion • Teach the client the proper use of a nasal spray devise; do not allow tip of container to touch nasal mucosa. Do not share with other people. • Teach signs of nasal fungal infection for clients using INS; discontinue use and report to primary health care provider Copyright © 2022 Wolters Kluwer · All Rights Reserved Nursing Process—Client Receiving an Upper Respiratory System Drug ❖ Evaluation • Was the therapeutic effect achieved and cough relieved? • Were adverse reactions: identified, reported, and managed? ▪ No evidence of injury ▪ Client has a clear airway ▪ Mucous membranes are moist and intact • Did client and family express confidence and demonstrate understanding of drug regimen? Copyright © 2022 Wolters Kluwer · All Rights Reserved Turn and Talk—Case Study #1 ❖ A client with the medical conditions of hypertension and dyslipidemia, is currently taking the medications metoprolol (Toprol XL) 50 mg every day, hydrochlorothiazide 25 mg every morning, and simvastatin 2 mg every day. The client sends an email to the physician’s office to inquire about what can be taken for nasal congestion. The triage nurse returns the email and asks if any self remedies have been tried and when the last vital sign recordings have been? The client tells the triage nurse nothing has been taken yet for the nasal congestion, and the client’s Apple Watch records a blood pressure of 125/80 mm Hg and pulse of 70 beats/minute. The client denied any other symptoms. Copyright © 2022 Wolters Kluwer · All Rights Reserved Turn and Talk—Case Study #2 1. Was the client’s call warranted? 2. What additional information does the triage nurse need to elicit from the client? 3. The physician recommends an over-the-counter nasal spray for the nasal congestion. Why is this the most appropriate treatment for this client? 4. What counseling should the triage nurse offer the client?","libVersion":"0.3.2","langs":""}